These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1026643)

  • 41. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 42. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anatomic and bacteriologic testing of rifampicin effectiveness in treatment of pulmonary tuberculosis].
    Morère P; Stain JP; Hubert J; Chauvet MC
    Rev Tuberc Pneumol (Paris); 1970; 34(3):434-8. PubMed ID: 4994941
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of new and chronic tuberculous patients with ethambutol and Rifampicin (author's transl)].
    Pregowski W; Stanczuk A; Znaniecka H; Cesarz-Fronczyk M
    Z Erkr Atmungsorgane; 1976 May; 145(2):220-6. PubMed ID: 983179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course].
    Horsfall PA
    Bull Int Union Tuberc; 1974; 49(1):447-51. PubMed ID: 4619566
    [No Abstract]   [Full Text] [Related]  

  • 46. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 47. Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
    Wiman LG; Johansson R; Tegner KB
    Scand J Respir Dis; 1973; 54(5):255-63. PubMed ID: 4777378
    [No Abstract]   [Full Text] [Related]  

  • 48. [Organizaton and effectiveness of controlled intermittent outpatient treatment with ethambutol and rifadin in fibro-carvernous pulmonary tuberculosis].
    Rudoi NM; Eisaev BA
    Probl Tuberk; 1975; (1):17-21. PubMed ID: 1144360
    [No Abstract]   [Full Text] [Related]  

  • 49. [Rifampicin, ethambutol and drugs of the 2d series in chemotherapy of chronic cavernous tuberculosis of the lungs].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1979 Nov; (11):20-6. PubMed ID: 530963
    [No Abstract]   [Full Text] [Related]  

  • 50. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cooperative clinical trials of efficacy of chemotherapy of patients with fibro-cavernous tuberculosis].
    Korotaev GA; Margulis NIu
    Probl Tuberk; 1982 Aug; (8):35-40. PubMed ID: 6755444
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experimental study of schedules for intermittent administration of rifampicin and ethambutol].
    Kozulitsyna TI; Petrov IV
    Probl Tuberk; 1976 May; (5):72-5. PubMed ID: 951412
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
    Cornudella R; Garcia-Besada JA; Castellano A
    Rev Clin Esp; 1972 Jul; 126(1):59-64. PubMed ID: 5080189
    [No Abstract]   [Full Text] [Related]  

  • 54. [Use of rifadin and ethambutol in pulmonary tuberculosis with concomitant diseases].
    Pak FP; Kertselli IuS
    Probl Tuberk; 1976 May; (5):78-80. PubMed ID: 951414
    [No Abstract]   [Full Text] [Related]  

  • 55. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immediate results of strictly supervised, intermittent treatment with rifampicin and ethambutol in patients with chronic pulmonary tuberculosis].
    Josefovics F; Vojth B; Vojth V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(1):35-8. PubMed ID: 191889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Functional state of the adrenal cortex in patients with pulmonary tuberculosis during treatment with rifampin and ethambutol].
    Rybak IuN
    Probl Tuberk; 1973; 51(10):31-3. PubMed ID: 4493156
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5146090
    [No Abstract]   [Full Text] [Related]  

  • 59. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract]   [Full Text] [Related]  

  • 60. First experience with rifampicin in retreatment of resistant cases.
    Tousek J
    Acta Tuberc Pneumol Belg; 1969; 60(3):478-81. PubMed ID: 5371672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.